CA2543132A1 - Procedes d'utilisations et compositions comprenant des medicaments selectifs inhibiteurs de la cytokine utilises dans le traitement, la modification et la gestion de la douleur - Google Patents
Procedes d'utilisations et compositions comprenant des medicaments selectifs inhibiteurs de la cytokine utilises dans le traitement, la modification et la gestion de la douleur Download PDFInfo
- Publication number
- CA2543132A1 CA2543132A1 CA002543132A CA2543132A CA2543132A1 CA 2543132 A1 CA2543132 A1 CA 2543132A1 CA 002543132 A CA002543132 A CA 002543132A CA 2543132 A CA2543132 A CA 2543132A CA 2543132 A1 CA2543132 A1 CA 2543132A1
- Authority
- CA
- Canada
- Prior art keywords
- carbon atoms
- pain
- alkyl
- substituted
- cytokine inhibitory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/693,722 US20040087558A1 (en) | 2002-10-24 | 2003-10-23 | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain |
US10/693,722 | 2003-10-23 | ||
PCT/US2004/012722 WO2005043971A2 (fr) | 2003-10-23 | 2004-04-23 | Procedes d'utilisations et compositions comprenant des medicaments selectifs inhibiteurs de la cytokine utilises dans le traitement, la modification et la gestion de la douleur |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2543132A1 true CA2543132A1 (fr) | 2005-05-19 |
Family
ID=36636802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002543132A Abandoned CA2543132A1 (fr) | 2003-10-23 | 2004-04-23 | Procedes d'utilisations et compositions comprenant des medicaments selectifs inhibiteurs de la cytokine utilises dans le traitement, la modification et la gestion de la douleur |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2007524656A (fr) |
CA (1) | CA2543132A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110200978A (zh) * | 2016-04-22 | 2019-09-06 | 维京治疗股份有限公司 | 甲状腺β-激动剂的应用 |
CN111743871A (zh) * | 2020-07-14 | 2020-10-09 | 天方药业有限公司 | 盐酸酚苄明片剂及其制备方法 |
US11951114B2 (en) | 2016-04-22 | 2024-04-09 | Viking Therapeutics, Inc. | Use of thyroid beta-agonists |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5463063A (en) * | 1993-07-02 | 1995-10-31 | Celgene Corporation | Ring closure of N-phthaloylglutamines |
US5726156A (en) * | 1995-03-06 | 1998-03-10 | Trega Biosciences, Inc. | Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
CZ299873B6 (cs) * | 1997-07-31 | 2008-12-17 | Celgene Corporation | Derivát hydroxamové kyseliny a farmaceutický prostredek s jeho obsahem |
US6020358A (en) * | 1998-10-30 | 2000-02-01 | Celgene Corporation | Substituted phenethylsulfones and method of reducing TNFα levels |
US6667316B1 (en) * | 1999-11-12 | 2003-12-23 | Celgene Corporation | Pharmaceutically active isoindoline derivatives |
SE0101256D0 (sv) * | 2001-04-06 | 2001-04-06 | A & Science Invest Ab | Treatment of low back pain |
US6962940B2 (en) * | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
-
2004
- 2004-04-23 CA CA002543132A patent/CA2543132A1/fr not_active Abandoned
- 2004-04-23 JP JP2006536543A patent/JP2007524656A/ja active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110200978A (zh) * | 2016-04-22 | 2019-09-06 | 维京治疗股份有限公司 | 甲状腺β-激动剂的应用 |
CN110200978B (zh) * | 2016-04-22 | 2023-10-31 | 维京治疗股份有限公司 | 甲状腺β-激动剂的应用 |
US11951114B2 (en) | 2016-04-22 | 2024-04-09 | Viking Therapeutics, Inc. | Use of thyroid beta-agonists |
CN111743871A (zh) * | 2020-07-14 | 2020-10-09 | 天方药业有限公司 | 盐酸酚苄明片剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
JP2007524656A (ja) | 2007-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200603461B (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain | |
AU2003284979B2 (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain | |
MX2007006992A (es) | Composiciones que comprenden moduladores pde4 y su uso para el tratamiento o prevencion de la inflamacion de las vias aereas. | |
EP1553951A2 (fr) | Compositions contenant un inhibiteur de jnk destinees a traiter, prevenir, gerer et/ou modifier la douleur, et leurs methodes d'utilisation | |
US20060106085A1 (en) | Methods and compositions using PDE4 modulators for treatment and management of central nervous system injury | |
AU2003286663B2 (en) | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain | |
US20070161696A1 (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain | |
US7612096B2 (en) | Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindoline | |
CA2543132A1 (fr) | Procedes d'utilisations et compositions comprenant des medicaments selectifs inhibiteurs de la cytokine utilises dans le traitement, la modification et la gestion de la douleur |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |